Arie Steinberg - Partner Independent Director
| PTNR Stock | ILA 1,655 30.00 1.78% |
Director
Mr. Arie Steinberg serves as Independent Director at Partner Communications Company Ltd. since January 2012. He is a member of the Audit and Compensation committees. His work experience includes the following roles Director at Leumi Partners Ltd., Member of the Board of Trustees of the Academic College of TelAvivYaffo, Chairman of the Board of Directors at Psagot Investment House Ltd. and some of its subsidiaries, Director at the TelAviv Stock Exchange, Chief Executive Officer at Ilanot Batucha Investment House, Director at Maalot, Managing Director at EtgarPortfolio Management Trust Co. and Member of the Advisory Boards of Mobileye Technologies and Novotrans Group SA. Mr. Steinberg studied Economics at TelAviv University. since 2012.
| Age | 54 |
| Tenure | 12 years |
| Phone | (972) 54 781 4999 |
| Web | www.partner.co.il |
Partner Management Efficiency
The company has return on total asset (ROA) of 0.036 % which means that it generated a profit of $0.036 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1131 %, meaning that it generated $0.1131 on every $100 dollars invested by stockholders. Partner's management efficiency ratios could be used to measure how well Partner manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ester Dominissini | Bank Leumi Le Israel | 67 | |
| Yehoshua Gleitman | Elbit Systems | 69 | |
| Yoram Gabbay | Bank Leumi Le Israel | 70 | |
| Avraham Asheri | Elbit Systems | 77 | |
| Haim Levy | Bank Leumi Le Israel | 77 | |
| Shmuel BenZvi | Bank Leumi Le Israel | 57 | |
| Joseph Nitzani | Teva Pharmaceutical Industries | 70 | |
| Ronit Rokach | Bank Hapoalim | 61 | |
| Yitzhak Peterburg | Teva Pharmaceutical Industries | 65 | |
| Moshe Many | Teva Pharmaceutical Industries | 85 | |
| Yael Karni | El Al Israel | 47 | |
| Moshe Dovrat | Bank Leumi Le Israel | 69 | |
| Ammon Dick | Bank Hapoalim | 62 | |
| Dafna Schwartz | Bank Hapoalim | 65 | |
| Yoram BenZeev | Elbit Systems | 74 | |
| Yedidia Stern | Bank Leumi Le Israel | 62 | |
| Ory Slonim | Teva Pharmaceutical Industries | 73 | |
| Richard Kaplan | Bank Hapoalim | 63 | |
| Jean Halfon | Teva Pharmaceutical Industries | 62 | |
| Nir Zichlinskey | Bank Hapoalim | 49 | |
| Herb Small | Bank Leumi Le Israel | N/A | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.036 |
Partner Leadership Team
Elected by the shareholders, the Partner's board of directors comprises two types of representatives: Partner inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Partner. The board's role is to monitor Partner's management team and ensure that shareholders' interests are well served. Partner's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Partner's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yael Gaoni, VP Communications | ||
| David Mizrahi, CFO | ||
| Addie Koren, COO HR | ||
| Raz Bartov, Vice President-Technologies & IT Division | ||
| Sigal Tzadok, CFO Department | ||
| Atara Shacham, Vice President-Marketing and Growth Engines Division | ||
| Noach Hacker, Vice President-Regulation & Fiber Division | ||
| Yehuda Saban, Director | ||
| Menahem Tirosh, COO | ||
| Advocate Sharabi, Head Department | ||
| Michael Anghel, External & Independent Director | ||
| Fred Gluckman, Director | ||
| Osnat Ronen, Independent Chairwoman of the Board | ||
| Gideon Koch, IR Officer | ||
| Jonathan Kolodny, External Independent Director | ||
| Amalia Glaser, Spokesman and VP Communications and Corporate Governance Division | ||
| Isaac Benbenisti, Chief Executive Officer | ||
| Tomer Zeev, Director | ||
| Barry Zeev, External & Independent Director | ||
| Ori Gal, VP Marketing | ||
| Yuval Keinan, Deputy Chief Executive Officer | ||
| Aviram Cohen, Vice President - Customers Division | ||
| Yakov Truzman, Vice President-Business Division | ||
| Hadar VismunskiWeinberg, Vice President Chief General Counsel, Corporate Secretary | ||
| Joseph Shachak, Director | ||
| Ronit Rubin, VP of Bus. Customer Division | ||
| Sumeet Jaisinghani, Director | ||
| Arie Steinberg, Independent Director | ||
| Arieh Saban, Director | ||
| Ori Watermann, Vice President - Fixed Line Division; CEO of 012 Smile Telecom Ltd. | ||
| Ori Yaron, Director | ||
| Yahel Shachar, Director | ||
| Sigalit Cohen, Vice President - Customer Service Division | ||
| Avraham Gabbay, Chief Officer | ||
| Tamir Amar, Chief Financial Officer | ||
| Ziv Leitman, CFO | ||
| Elon Shalev, Vice Chairman of the Board | ||
| Nomi Sandhaus, Vice President General Counsel, Secretary and Regulatory Affairs | ||
| Einat Rom, Vice President - Human Resources & Administration | ||
| Sarit Hecht, Chief VP | ||
| Yoav Rubinstein, Director | ||
| Liran Dan, Vice President - Strategy & Business Development | ||
| Zvika Shenfeld, Acting Head - Marketing, Content and Growth Engines Division | ||
| Richard Hunter, Director | ||
| Amir Adar, Head Projects | ||
| Guy Emodi, Vice President - Economics & Planning, Corporate Strategy and Operator Relations | ||
| Terry Yaskil, Vice President-Marketing & Growth Engines Division | ||
| Barak Pridor, Director | ||
| Adam Chesnoff, Chairman of the Board | ||
| Yaron Eisenstein, Vice President - Technologies & IT Division |
Partner Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Partner a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.036 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 5.83 B | |||
| Shares Outstanding | 186.27 M | |||
| Shares Owned By Insiders | 33.93 % | |||
| Shares Owned By Institutions | 45.87 % | |||
| Price To Book | 2.21 X | |||
| Price To Sales | 1.29 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Partner in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Partner's short interest history, or implied volatility extrapolated from Partner options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Partner using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Partner. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Partner Stock analysis
When running Partner's price analysis, check to measure Partner's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Partner is operating at the current time. Most of Partner's value examination focuses on studying past and present price action to predict the probability of Partner's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Partner's price. Additionally, you may evaluate how the addition of Partner to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |